Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 57

Cleerly captures $43m in series B round

The cardiovascular data technology developer has launched with $54m in funding, $43m coming from a Cigna Ventures-backed series B round.

Jun 22, 2021

Daily Deal Round Up: June 21, 2021

Tencent, Credit Saison and JG Summit have all contributed to a $16m round for GrowSari while Greenvolt is set to acquire up to 29% of solar system installer Perfecta Energía.

Jun 21, 2021

Enough tops up funding with series B

Nutreco co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.

Jun 21, 2021

Dydx determines $65m series C close

Several companies operating in the digital asset and cryptocurrency markets have invested in a series C round for the decentralised exchange platform operator.

Jun 21, 2021

Daily Deal Round Up: June 18, 2021

Behavioural health platform developer Brightline captured $72m in a round led by GV, while Gopuff is set to buy Siemens and ST-backed mobility software producer RideOS.

Jun 18, 2021

Vision Fund helps Vianai find $140m

SoftBank Vision Fund 2 led artificial intelligence technology developer Vianai Systems' series A round, participating alongside a range of private investors.

Jun 18, 2021

Daily Deal Round Up: June 17, 2021

11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.

Jun 17, 2021

Motif FoodWorks makes $226m series B move

Motif FoodWorks, launched by Gingko Bioworks, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Gingko agreed to a reverse merger.

Jun 17, 2021

Umoja draws on SoftBank for $210m

SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.

Jun 17, 2021

Apollo assembles investors for $145m round

The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.

Jun 17, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here